Who We Are
Our team at Nevada Oncology Specialists aims to provide an innovative, caring, and cost-effective alternative to the existing practices in Clark County, and our services will be integrated closely with those of other cancer specialists. Our physicians have been practicing in Clark County for many years and have led the way for quality Las Vegas radiation and medical oncology treatments. In addition, they have built excellent relationships with patients, referring physicians, and insurers. We value maintaining open lines of communication and keeping both patients and primary care physicians involved in our patients' care.
Medical Oncologist
EDUCATION
Dr. Samlowski earned his bachelor’s and medical degree from the Ohio State University in Columbus, Ohio. He completed his internal medicine residency at Wayne State University in Detroit and his hematology/oncology fellowship at the University of Utah in Salt Lake City.
AREAS OF SPECIAL INTEREST
Melanoma, other skin malignancies, sarcoma, and head and neck
EXPERIENCE
Dr. Wolfram Samlowski is a Nevada Oncology Specialists (NOS) medical oncologist. He is a Clinical Professor of Medicine at UNLV Kirk Kerkorian School of Medicine. Dr. Samlowski is an expert in treating patients with melanoma and skin cancer, sarcoma, and head and neck cancer. He is active in health economics and outcomes research and has been the principle investigator on numerous clinical research studies.
Dr. Samlowski has contributed to and authored over 250 peer-reviewed publications, reviews, and scientific abstracts. He is a member of several professional associations, including the American Federation of Clinical Research, the American Society for Clinical Oncology, the American Association for Cancer Research, and the Society for Pigment Cell and Melanoma Research. He is also a Fellow of the American College of Physicians.
Before joining NOS, Dr. Samlowski was a Professor of Oncology and Adjunct Dermatology and Pathology at the Huntsman Cancer Institute of the University of Utah. Dr. Samlowski also served as director of Translational Research, Multidisciplinary Melanoma program at the Huntsman Cancer Institute, where he worked from 1984 to 2007. In 2007, he joined the Nevada Cancer Institute as Chief of Melanoma, Renal Cancer, and Immunotherapy and was appointed Professor of Oncology at the University of Nevada. He spent 13 years at Comprehensive Cancer Centers of Nevada before joining NOS.
Over the years, Dr. Samlowski has received numerous awards and honors. He has been named a “Top Doctor” by Vegas Seven and Las Vegas Life, “Best Doctor” by Desert Companion, and “America’s Top Doctors” and “America’s Top Oncologists” by Castle Connolly and US News and World Report. He was also named a “Healthcare Headliner” by Vegas, Inc. and “Medical Marvel” by Nevada Business Magazine.
BOARD CERTIFIED
Medical Oncology
Internal Medicine
MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS
American College of Physicians (ACS), Fellow
American Federation of Clinical Research AFCR
American Society for Clinical Oncology (ASCO)
American Association for Cancer Research (AACR)
Society for Pigment Cell and Melanoma Research (SMR)
Society for Immunotherapy of Cancer (SITC)
Clark County Medical Society (CCMS)
Medical Oncologist
EDUCATION
Dr. Oscar B. Goodman Jr. completed his undergraduate studies at Swarthmore College in Pennsylvania, earned his medical degree at Jefferson Medical College and his PhD at Thomas Jefferson University, both in Philadelphia. Dr. Goodman completed his internship and residency in internal medicine, and fellowships in hematology and medical oncology at New York Presbyterian Hospital, Weill Cornell Campus, in New York City.
AREAS OF SPECIAL INTEREST
Genitourinary Malignancies (prostate, kidney, bladder and testicular cancers); Basic, Translational, and Clinical Research
EXPERIENCE
Dr. Goodman is a physician-scientist. He is coming to Nevada Oncology Specialists from Comprehensive Cancer Centers of Nevada, where he has been hematologist, medical oncologist and clinical researcher since 2012. His clinical expertise and practice focus is Genitourinary Oncology. He routinely incorporates various cutting edge clinical trials into his practice.
His translational research projects center around understanding mechanisms that govern prostate cancer’s resistance to hormonal therapy. He conducts prostate cancer research at Roseman University of Health Sciences, with colleagues on the Prostate Cancer Research team, part of the University’s Cancer Research Program. He serves as an Associate Professor of Internal Medicine at Roseman University College of Medicine.
Prior to joining CCCN, Dr. Goodman worked as a medical oncologist at the UC San Diego Nevada Cancer Institute. Before moving to Las Vegas, Dr. Goodman worked as a Clinical Associate and later as a physician for the Department of Medicine, Division of Hematology/Oncology, at New York Presbyterian Hospital, Weill Cornell Campus, in New York City.
He has earned multiple awards during his career. Dr. Goodman is a recipient of the Young Investigator Award from the American Society of Clinical Oncology and has been named a Regional Top Doctor by US News and World Report and Castle-Connolly annually since 2008. He has been honored with the title of Research Healthcare Headliner by Vegas Inc. and received the 2014 Southern Nevada Technology & Research Healthcare Hero award by Nevada Business Magazine. He was awarded the Inspired Excellence in Health Care Award by Las Vegas HEALS. He is consistently recognized as a Top Doctor by Vegas Inc. and Desert Companion in its annual polls.
He has authored numerous abstracts, book chapters, and more than 45 peer-reviewed publications. He has received peer-reviewed translational research support through the Department of Defense for his prostate cancer research.
Former Director of Proton Therapy, Dept. of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center.
Adjunct Clinical Professor, Dept. of Radiation Medicine and Applied Sciences, University of California at San Diego.
Co-Chair of the Publication Committee and member of Executive Committee of PTCOG (Particle Beam Therapy Co-Operative Group) (2013 – 2019.)
Co-Editor-in-Chief for the International Journal of Medical Physics, Clinical Engineering, and Radiation Oncology.
Co-Editor-in-Chief for the Translational Cancer Research Journal.
Dr. Giap received his graduate degree in nuclear engineering (cum laude) from Texas A&M University in 1986. After working at a commercial nuclear reactor in Texas for several years, he was accepted into the M.D./Ph.D. Medical Scientist Training Program at the University of Texas Health Science Center at Houston (UTHSCH), where he completed both Medical Doctor and Doctor of Philosophy in Medical Physics degrees at the University of Texas M.D. Anderson Cancer Center in 1994.
For his dissertation, he developed a three-dimensional treatment planning software for systemic radionuclide therapy, and his research won him the award at the Young Investigator Symposium at American Association of Physicists in Medicine annual meeting 1993. He did his residency training at Loma Linda University Medical Center with focus on proton beam therapy. After that, he completed a clinical fellowship at Scripps Clinic in stereotactic radiosurgery and brachytherapy.
He worked as a clinical radiation oncologist at Scripps Clinic from 1998 to 2008. He was the Director of Clinical Research and Chief of GI, Lung, and Breast at the Scripps Proton Therapy Center.
While serving on PTCOG’s Publication Committee and Executive Committee, he created subcommittees for GI, H&N, breast sites. As PTCOG’s Congress President, he organized and hosted the annual international PTCOG 54th annual meeting in San Diego for 2015.
He has done research in, published, and given talks in the field of particle beam therapy, vascular brachytherapy to prevent coronary artery restenosis, biophysical modeling, radio-labeled antibody, stereotactic radiosurgery, partial breast irradiation, and radio-embolization with Y-90 microspheres.
He has an affiliated volunteer appointment of Clinical Professor in the Department of Radiation Medicine and Applied Sciences at UCSD and is currently developing the University of Miami’s proton therapy program.
He is the editor for the book “Particle Beam Therapy: Contemporary Trends and Reviews” (AME Publishing 2014). He was one of the contributors to the American College of Radiology (ACR) and American Society of Radiation Oncology (ASTRO) for several clinical guidelines (Radioembolization with Brachytherapy Device Yttrium-90 micro-spheres and Total Body Irradiation). He gave refresher courses at the annual ASTRO national meetings (2001, 2005, and 2006) on the topic of “Vascular brachytherapy” and “Radiation therapy for benign diseases.” He served as a member of the ASTRO Annual Meeting and Program committee as well as the Information Technology Development and Resource Committee.